Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TRPV2/TRPV3/TRPV4 group consists of three distinct non-selective cation channels within the vanilloid subfamily of the transient receptor potential (TRP) superfamily [1]. These channels are critical sensory transducers that respond to a variety of physical and chemical stimuli, including temperature, mechanical stress, and osmotic pressure [2]. TRPV2 is involved in high-threshold thermosensation and immune cell functions, while TRPV3 is predominantly expressed in skin keratinocytes where it regulates hair growth and barrier integrity [1, 3]. TRPV4 serves as a versatile mechanosensor and osmosensor, playing key roles in vascular tone, bone homeostasis, and lung fluid balance [2, 4]. Dysregulation of these channels is implicated in numerous pathologies, such as chronic pain, inflammatory skin diseases (e.g., atopic dermatitis), skeletal dysplasias, and pulmonary edema [3, 5]. Pharmacological modulation, particularly through small-molecule antagonists like GSK2798745, is a major area of drug development for treating respiratory, dermatological, and musculoskeletal disorders [5].
These channels are primarily targeted by small-molecule antagonists to inhibit calcium influx and downstream signaling pathways associated with pain, inflammation, and fluid homeostasis. Some compounds, such as cannabidiol, act as agonists that can lead to channel desensitization, while others like tranilast specifically inhibit channel activity to treat allergic and inflammatory conditions.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily V members 2, 3, and 4 (TRPV2/3/4).